NCT00370786
Completed
Phase 3
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
Overview
- Phase
- Phase 3
- Intervention
- bevacizumab
- Conditions
- Choroidal Neovascularization
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- Visual acuity
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc
Investigators
Eligibility Criteria
Inclusion Criteria
- •Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause.
Exclusion Criteria
- •Evidence of AMD
Arms & Interventions
1
Intervention: bevacizumab
Outcomes
Primary Outcomes
Visual acuity
Time Frame: 6 months
Secondary Outcomes
- central macular thickness(6 months)
- leakage in fluorescein angiography(6 months)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Intravitreal Bevacizumab in Agioid StreaksAngioid StreaksChoroidal NeovascularizationNCT00406250University of Campania "Luigi Vanvitelli"5
Terminated
Phase 3
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid StreaksAngioid StreaksChoroidal NeovascularizationNCT00599820Asociación para Evitar la Ceguera en México
Completed
Phase 4
Bevacizumab Intravitreal for Myopic Choroidal NeovascularizationMyopic Choroidal NeovascularizationNCT00797992Instituto de Olhos de Goiania5
Terminated
Phase 3
Efficacy of Retreatments With Intravitreal BevacizumabAge Related Macular DegenerationChoroidal NeovascularizationNCT00406744Asociación para Evitar la Ceguera en México20
Completed
Phase 4
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular DegenerationAge Related Macular DegenerationNCT00556348Instituto de Olhos de Goiania500